Skip to content

Clinical trials

Completed Mesothelioma, Malignant trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Status: Completed Country / region: Italy Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20091
20101
20112
20122
20132
20142
20152
20172
20181
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
AGC Biologics S.p.A.3
Armando Santoro, MD3
Istituto Clinico Humanitas3
Mario Negri Institute for Pharmacological Research2
Eli Lilly and Company1
Ferring Ventures Limited1
Istituto Oncologico Veneto IRCCS1
NovoCure Ltd.1
Polaris Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant21
Mesothelioma6
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Lung Neoplasms1
Lymphoma1
Lymphoma, Non-Hodgkin1
Neoplasm Metastasis1
Solitary Fibrous Tumor, Pleural1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.